FDA requiring Color Changes to the Writing on Duragesic Pain Patches

As seen in the Consultant Connection November 2013 Issue

The U.S. Food and Drug Administration is alerting the public that it is requiring color changes to the writing on Duragesic® (fentanyl) pain patches so they can be seen more easily. 
In an effort to minimize the risk of accidental exposure to fentanyl patches, FDA is requiring the manufacturer of Duragesic® to print the name and strength of the drug on the patch in long-lasting ink, in a color that is clearly visible to patients and caregivers. The current ink color varies by strength and is not always easy to see. This change is intended to enable patients and caregivers to more easily find patches on patients’ bodies and see patches that have fallen off, which children or pets could accidentally touch or ingest. The manufacturers of generic fentanyl patches are being requested to make similar changes.
Patients and caregivers should be aware that patches that are not stuck to the skin tightly enough may accidentally fall off a patient, posing a potential hazard to individuals in close contact, such as a child.
Used fentanyl patches require proper disposal after use. Fold the patch, sticky sides together, and flush it down the toilet with a witness to document destruction.
Go to: http://www.fda.gov/Drugs/DrugSafety/ucm368902.htm to view the FDA Drug Safety Communication which includes a data summary as well as recommendations for patients, caregivers, and health professionals.

Back to Articles